Open AccessInfant Growth Outcomes After Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy
Author(s) -
Carla E. Ransom,
Yanling Huo,
Kunjal Patel,
Gwendolyn B. Scott,
Heather Watts,
Paige L. Williams,
George K. Siberry,
Elizabeth Livingston
Publication year - 2013
Publication title -
jaids journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3182a7adb2
Subject(s) - medicine , pregnancy , birth weight , underweight , low birth weight , gestational age , obstetrics , confidence interval , odds ratio , in utero , population , regimen , gestation , pediatrics , fetus , body mass index , biology , overweight , genetics , environmental health
To determine whether maternal use of tenofovir disoproxil fumarate for treatment of HIV in pregnancy predicts fetal and infant growth.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom